miGut-Health (101095470)
https://cordis.europa.eu/project/id/101095470
Horizon Europe (2021-2027)
Personalised blueprint intestinal health
Personalised blueprint of chronic inflammation in health-to-disease transition (HORIZON-HLTH-2022-STAYHLTH-02-01)
eHealth · inflammatory bowel disease · immunology · nutrition · sensors
2023-01-01 Start Date (YY-MM-DD)
2026-12-31 End Date (YY-MM-DD)
€ 7,131,243
Description
The miGut-Health consortium aims to develop a personalized blueprint of intestinal health to predict and prevent inflammatory bowel disease. The overall goal is to deliver interdisciplinary solutions (molecular, nutritional, eHealth and patient engagement/empowerment level) for health promotion and disease prevention that would enable active patient engagement in health and self-care management. Taking on this mission, miGut-Health pursues the following strategic goals: - To integrate state-of-the-art omics (molecular, clinical, nutrition, social and environmental) for identification of actionable biomarkers, risk and health promoting factors linked to health-to-disease transition in the general population, IBD high risk persons, as well as IBD patients. - To perform systems-level analyses of chronic inflammation by applying integrative models from omics and clinical data to predict risk for health-to-disease transition in IBD. - To perform a proof-of-concept controlled clinical trial studying a nutrient elimination diet (here: gluten-free diet) and its impact on intestinal inflammation in IBD patients and high-risk individuals. - To exploit the impact of microbiome-derived diet-associated metabolites on gut inflammation reversion and restoration of barrier integrity and function using an innovative co-culture system of primary human intestinal organoids and sorted immune cell subsets. - To develop and apply novel technologies (sensors, mobile apps) to dynamically monitor individual nutrition as well as physical activity and principal health status. - To implement a patient-centered approach for personalized health and self-care engagement targeted at IBD patients, individuals at risk for IBD and the general population as well as tools for health-care professionals.
Complicit Organisations
1 Israeli organisation participates in miGut-Health.Country | Organisation (ID) | VAT Number | Role | Activity Type | Total Cost | EC Contribution | Net EC Contribution |
---|---|---|---|---|---|---|---|
Denmark | REGION HOVEDSTADEN (999654744) | DK30113721 | participant | PUB | € 338,625 | € 338,625 | € 338,625 |
Israel | WEIZMANN INSTITUTE OF SCIENCE (999979306) | IL520016858 | participant | HES | € 700,000 | € 700,000 | € 700,000 |
Germany | UNIVERSITATSKLINIKUM SCHLESWIG-HOLSTEIN (999845349) | DE814167313 | coordinator | HES | € 2,643,625 | € 2,638,625 | € 2,638,625 |
Germany | EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH (999778419) | DE210372698 | participant | PRC | € 487,874 | € 487,874 | € 327,874 |
Netherlands | ACADEMISCH ZIEKENHUIS GRONINGEN (999914801) | NL800866393B01 | participant | HES | € 659,175 | € 659,175 | € 659,175 |
Germany | CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL (999839529) | DE811317279 | thirdParty | HES | € 5,000 | € 0 | € 0 |
Switzerland | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (999973971) | CHE116075613TVA | associatedPartner | HES | € 0 | € 0 | € 0 |
Belgium | EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS (926739941) | BE0459814543 | participant | OTH | € 135,950 | € 135,950 | € 135,950 |
Lithuania | LIETUVOS SVEIKATOS MOKSLU UNIVERSITETAS (972782446) | LT100005579315 | participant | HES | € 624,995 | € 624,995 | € 624,995 |
Germany | UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF (999857474) | DE218618948 | participant | HES | € 714,200 | € 714,200 | € 714,200 |
Croatia | RESEARCH AND INNOVATION SERVICES DOO ZA USLUGE (884077013) | HR62531146422 | thirdParty | PRC | € 160,000 | € 0 | € 160,000 |
Sweden | OREBRO UNIVERSITY (999650088) | SE202100292401 | participant | HES | € 429,924 | € 429,924 | € 429,924 |
Italy | UNIVERSITA CATTOLICA DEL SACRO CUORE (999915771) | IT02133120150 | participant | HES | € 396,875 | € 396,875 | € 396,875 |